Logo image of ESPO

VANECK VIDEOGAMING ESPORTS (ESPO) Stock Price, Quote, News and Overview

NASDAQ:ESPO - Nasdaq - US92189F1140 - ETF - Currency: USD

90.24  -0.17 (-0.19%)

Fundamental Rating

4

ESPO gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 0 industry peers in the Unkown industry. ESPO has only an average score on both its financial health and profitability. ESPO has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

ESPO had positive earnings in the past year.
In the past year ESPO had a positive cash flow from operations.
Each year in the past 5 years ESPO has been profitable.
In the past 5 years ESPO always reported a positive cash flow from operatings.
ESPO Yearly Net Income VS EBIT VS OCF VS FCFESPO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1B 2B 3B 4B 5B

1.2 Ratios

ESPO's Return On Assets of 5.28% is in line compared to the rest of the industry. ESPO outperforms 49.40% of its industry peers.
ESPO has a Return On Equity (10.77%) which is comparable to the rest of the industry.
The Return On Invested Capital of ESPO (9.29%) is comparable to the rest of the industry.
The last Return On Invested Capital (9.29%) for ESPO is above the 3 year average (9.16%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 5.28%
ROE 10.77%
ROIC 9.29%
ROA(3y)5.54%
ROA(5y)4.82%
ROE(3y)11.67%
ROE(5y)10.63%
ROIC(3y)9.16%
ROIC(5y)8.51%
ESPO Yearly ROA, ROE, ROICESPO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 5 10 15

1.3 Margins

ESPO's Profit Margin of 6.93% is in line compared to the rest of the industry. ESPO outperforms 51.81% of its industry peers.
In the last couple of years the Profit Margin of ESPO has declined.
ESPO has a Operating Margin of 12.44%. This is comparable to the rest of the industry: ESPO outperforms 55.42% of its industry peers.
ESPO's Operating Margin has been stable in the last couple of years.
ESPO has a Gross Margin (29.25%) which is comparable to the rest of the industry.
ESPO's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 12.44%
PM (TTM) 6.93%
GM 29.25%
OM growth 3Y10.53%
OM growth 5Y-0.4%
PM growth 3Y31.62%
PM growth 5Y-1.53%
GM growth 3Y0.15%
GM growth 5Y-1.05%
ESPO Yearly Profit, Operating, Gross MarginsESPO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 10 20 30

5

2. Health

2.1 Basic Checks

The number of shares outstanding for ESPO remains at a similar level compared to 1 year ago.
Compared to 5 years ago, ESPO has less shares outstanding
The debt/assets ratio for ESPO has been reduced compared to a year ago.
ESPO Yearly Shares OutstandingESPO Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M
ESPO Yearly Total Debt VS Total AssetsESPO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 10B 20B 30B

2.2 Solvency

An Altman-Z score of 3.93 indicates that ESPO is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.93, ESPO belongs to the top of the industry, outperforming 81.93% of the companies in the same industry.
The Debt to FCF ratio of ESPO is 2.88, which is a good value as it means it would take ESPO, 2.88 years of fcf income to pay off all of its debts.
ESPO has a Debt to FCF ratio (2.88) which is comparable to the rest of the industry.
A Debt/Equity ratio of 0.40 indicates that ESPO is not too dependend on debt financing.
ESPO has a Debt to Equity ratio of 0.40. This is in the lower half of the industry: ESPO underperforms 61.45% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF 2.88
Altman-Z 3.93
ROIC/WACCN/A
WACCN/A
ESPO Yearly LT Debt VS Equity VS FCFESPO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5B 10B 15B

2.3 Liquidity

ESPO has a Current Ratio of 1.82. This is a normal value and indicates that ESPO is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.82, ESPO is not doing good in the industry: 68.67% of the companies in the same industry are doing better.
A Quick Ratio of 1.11 indicates that ESPO should not have too much problems paying its short term obligations.
ESPO's Quick ratio of 1.11 is on the low side compared to the rest of the industry. ESPO is outperformed by 69.88% of its industry peers.
Industry RankSector Rank
Current Ratio 1.82
Quick Ratio 1.11
ESPO Yearly Current Assets VS Current LiabilitesESPO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 5B 10B 15B

3

3. Growth

3.1 Past

The earnings per share for ESPO have decreased strongly by -19.52% in the last year.
The Earnings Per Share has been growing slightly by 3.63% on average over the past years.
The Revenue has decreased by -5.57% in the past year.
The Revenue has been growing slightly by 5.17% on average over the past years.
EPS 1Y (TTM)-19.52%
EPS 3Y46.69%
EPS 5Y3.63%
EPS Q2Q%-5.33%
Revenue 1Y (TTM)-5.57%
Revenue growth 3Y11.46%
Revenue growth 5Y5.17%
Sales Q2Q%-4.25%

3.2 Future

ESPO is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.57% yearly.
Based on estimates for the next years, ESPO will show a small growth in Revenue. The Revenue will grow by 2.41% on average per year.
EPS Next Y18.07%
EPS Next 2Y13.1%
EPS Next 3Y12.8%
EPS Next 5Y11.57%
Revenue Next Year-4.7%
Revenue Next 2Y-0.7%
Revenue Next 3Y0.65%
Revenue Next 5Y2.41%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ESPO Yearly Revenue VS EstimatesESPO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 10B 20B 30B
ESPO Yearly EPS VS EstimatesESPO Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1 2 3 4

1

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 32.34, ESPO can be considered very expensive at the moment.
ESPO's Price/Earnings ratio is a bit more expensive when compared to the industry. ESPO is more expensive than 71.08% of the companies in the same industry.
ESPO's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 29.75.
The Price/Forward Earnings ratio is 24.46, which indicates a rather expensive current valuation of ESPO.
72.29% of the companies in the same industry are cheaper than ESPO, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.44, ESPO is valued at the same level.
Industry RankSector Rank
PE 32.34
Fwd PE 24.46
ESPO Price Earnings VS Forward Price EarningsESPO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ESPO is valued a bit more expensive than the industry average as 69.88% of the companies are valued more cheaply.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of ESPO indicates a slightly more expensive valuation: ESPO is more expensive than 65.06% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 21.35
EV/EBITDA 12.24
ESPO Per share dataESPO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as ESPO's earnings are expected to grow with 12.80% in the coming years.
PEG (NY)1.79
PEG (5Y)8.91
EPS Next 2Y13.1%
EPS Next 3Y12.8%

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 4.00%, ESPO is a good candidate for dividend investing.
Compared to an average S&P500 Dividend Yield of 2.30, ESPO pays a better dividend.
Industry RankSector Rank
Dividend Yield 4%

5.2 History

The dividend of ESPO is nicely growing with an annual growth rate of 7.12%!
ESPO has been paying a dividend for over 5 years, so it has already some track record.
ESPO has decreased its dividend recently.
Dividend Growth(5Y)7.12%
Div Incr Years1
Div Non Decr Years1
ESPO Yearly Dividends per shareESPO Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 0.5 1 1.5 2

5.3 Sustainability

50.00% of the earnings are spent on dividend by ESPO. This is a bit on the high side, but may be sustainable.
ESPO's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP50%
EPS Next 2Y13.1%
EPS Next 3Y12.8%
ESPO Yearly Income VS Free CF VS DividendESPO Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1B 2B 3B
ESPO Dividend Payout.ESPO Dividend Payout, showing the Payout Ratio.ESPO Dividend Payout.PayoutRetained Earnings

VANECK VIDEOGAMING ESPORTS

NASDAQ:ESPO (3/3/2025, 8:00:02 PM)

90.24

-0.17 (-0.19%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner Change10.3%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap0
Analysts75.71
Price Target94.53 (4.75%)
Short Float %0.01%
Short Ratio1.4
Dividend
Industry RankSector Rank
Dividend Yield 4%
Yearly Dividend1.3
Dividend Growth(5Y)7.12%
DP50%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-2.82%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0.39%
EPS NY rev (3m)-2.3%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.33%
Revenue NY rev (3m)-0.27%
Valuation
Industry RankSector Rank
PE 32.34
Fwd PE 24.46
P/S 2.25
P/FCF 21.35
P/OCF 12.02
P/B 3.5
P/tB 4.78
EV/EBITDA 12.24
EPS(TTM)2.79
EY3.09%
EPS(NY)3.69
Fwd EY4.09%
FCF(TTM)4.23
FCFY4.68%
OCF(TTM)7.51
OCFY8.32%
SpS40.14
BVpS25.82
TBVpS18.89
PEG (NY)1.79
PEG (5Y)8.91
Profitability
Industry RankSector Rank
ROA 5.28%
ROE 10.77%
ROCE 12.25%
ROIC 9.29%
ROICexc 10.6%
ROICexgc 13.08%
OM 12.44%
PM (TTM) 6.93%
GM 29.25%
FCFM 10.53%
ROA(3y)5.54%
ROA(5y)4.82%
ROE(3y)11.67%
ROE(5y)10.63%
ROIC(3y)9.16%
ROIC(5y)8.51%
ROICexc(3y)10.41%
ROICexc(5y)9.64%
ROICexgc(3y)12.74%
ROICexgc(5y)11.9%
ROCE(3y)12.06%
ROCE(5y)11.19%
ROICexcg growth 3Y13.26%
ROICexcg growth 5Y0.75%
ROICexc growth 3Y14.02%
ROICexc growth 5Y1.17%
OM growth 3Y10.53%
OM growth 5Y-0.4%
PM growth 3Y31.62%
PM growth 5Y-1.53%
GM growth 3Y0.15%
GM growth 5Y-1.05%
F-Score6
Asset Turnover0.76
Health
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF 2.88
Debt/EBITDA 1.31
Cap/Depr 116.24%
Cap/Sales 8.18%
Interest Coverage 10.15
Cash Conversion 96.06%
Profit Quality 152.03%
Current Ratio 1.82
Quick Ratio 1.11
Altman-Z 3.93
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)109.9%
Cap/Depr(5y)100.41%
Cap/Sales(3y)7.51%
Cap/Sales(5y)7.19%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-19.52%
EPS 3Y46.69%
EPS 5Y3.63%
EPS Q2Q%-5.33%
EPS Next Y18.07%
EPS Next 2Y13.1%
EPS Next 3Y12.8%
EPS Next 5Y11.57%
Revenue 1Y (TTM)-5.57%
Revenue growth 3Y11.46%
Revenue growth 5Y5.17%
Sales Q2Q%-4.25%
Revenue Next Year-4.7%
Revenue Next 2Y-0.7%
Revenue Next 3Y0.65%
Revenue Next 5Y2.41%
EBIT growth 1Y2.68%
EBIT growth 3Y23.2%
EBIT growth 5Y4.75%
EBIT Next Year61.62%
EBIT Next 3Y21.75%
EBIT Next 5Y16.53%
FCF growth 1Y7589.47%
FCF growth 3Y12.46%
FCF growth 5Y21.28%
OCF growth 1Y171.92%
OCF growth 3Y16.24%
OCF growth 5Y13.31%